LifeVantage
Corporation(OTCBB:LFVN), the maker of Protandim®,
the only product clinically proven to slow the progressive rate of
aging, announced the company has joined forces with Cornerstone Research
and Development, Inc., a leading manufacturer owned by Mitsui USA, to
dramatically cut product manufacturing costs.
David Brown, LifeVantage President and CEO, said, "By
utilizing Cornerstone's manufacturing
efficiencies, we are able to significantly lower our costs of
manufacturing Protandim.
The net result will be an approximate 50 percent decrease in
manufacturing costs."
Additionally, David Brown commented, "The
formation of a partnership with Cornerstone is an exciting development
for LifeVantage. Cornerstone's
industry-leading Good Manufacturing Practices (GMP) will allow us to not
only save money, but maintain the high quality standards for which
Protandim® is known. Cornerstone's
GMP certifications will now allow us to pursue endorsement opportunities
involving professional athletes and teams, as well as more easily
achieve product registration in Canada and in other countries that have
previously been unavailable to us."
About
Cornerstone Research and Development, Inc.
Cornerstone Research and Development, Inc. formulates and manufactures
hundreds of dietary supplement products, including single herb and
herbal formulas, vitamins, mineral, homeopathy, and specialty formulas.
Based in Utah, the manufacturing company uses cutting-edge capabilities
to specialize in research, packaging, and developing supplement
products. For more information, please visit www.cornerstonerdi.com.
About Protandim®
Protandim® is a
groundbreaking, clinically proven solution for healthy aging. This
patented anti-oxidant therapy is 1000's of
times more powerful than red wine, oranges, blueberries, acai juice or
other popular anti-oxidant supplements. Protandim works by increasing
the body's natural anti-oxidant protection at
the cellular level, triggering cells to produce naturally occurring
protective antioxidant enzymes such as super oxide dismutase (SOD),
catalase, and glutathione. A peer-reviewed scientific study shows that
after 30 days of taking Protandim, free radicals decreased an average of
40 percent, slowing the progressive aging factors to the level of a 20
year old. Protandim is currently the subject of over 20 scientific
studies at leading universities and research institutes. For more
information, please visit the Protandim®
product web site at www.protandim.com
or contact Jan Strode at (619) 890-4040.
About
LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB:LFVN), science
based, natural products company, dedicated to helping people reach their
health and wellness goals through science-based solutions to oxidative
stress. Founded in 2003 and based in Colorado, LifeVantage develops
nutraceutical products, including Protandim,
that leverage the company's expertise and that are intended to deliver
significant health benefits to consumers. For more information, visit www.lifevantage.com
or contact Jan Strode at (619) 890-4040.
This document contains forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995.The Company uses the words "anticipate,""believe,""could,""should,""estimate,""expect,""intend,""may,""predict,""project,""plan,""target" and
similar terms and phrases, including references to assumptions, to
identify forward-looking statements.These forward-looking
statements are based on the Company's current
expectations and beliefs concerning future events affecting the Company
and involve known and unknown risks and uncertainties that may cause the
Company's actual results or outcomes to be materially different from
those anticipated and discussed herein.These risks and
uncertainties include, among others, the risk that government regulators
and regulations could adversely affect our business; future laws or
regulations may hinder or prohibit the production or sale of our
existing product and any future products; unfavorable publicity could
materially hurt our business; and the Company's
ability to protect our intellectual property rights and the value of our
product.These and other risk factors are discussed in greater
detail in the Company's Annual Report on Form
10-KSB under the caption "Risk Factors,"
and in other documents filed the Company from time to time with the
Securities and Exchange Commission.The Company cautions
investors not to place undue reliance on the forward-looking statements
contained in this document.All forward-looking statements are
based on information currently available to the Company on the date
hereof, and the Company undertakes no obligation to revise or update
these forward-looking statements to reflect events or circumstances
after the date of this document, except as required by law.
* These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
Note to Editors: Contact Jan Strode at 619-890-4040 for interviews,
photography, and other requests.
LifeVantage Corporation
Jan Strode, 619-890-4040